v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 7 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (7,712) $ 396,872
Adjustments to reconcile net income to net cash used in operating activities:    
Income earned on marketable securities held in Trust Account (3,089,290)
Changes in operating assets and liabilities:    
Prepaid Expenses (163,017)
Accounts payable and accrued expenses 3,124 2,265,347
Related party payable 111,190 (111,190)
Net cash used in operating activities 106,602 (701,278)
Cash Flows from Investing Activities:    
Cash deposited in Trust Account (86,250,000)
Net cash used in investing activities (86,250,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of founder shares 25,000
Deferred offering costs associated with proposed public offering (131,602)
Proceeds received from the initial public offering, gross 86,250,000
Proceeds received from private placement 2,656,250
Proceeds from Sponsor Loan 500,000
Offering costs paid (2,429,227)
Net cash provided by financing activities (106,602) 86,977,023
Net increase in cash 25,745
Cash - beginning of the period
Cash - ending of the period 25,745
Supplemental disclosure of noncash investing and financing activities:    
Payment of deferred offering costs included in Related party payable balance 131,602
Proceeds allocated to public rights 7,848,750
Allocation of offering costs to ordinary shares subject to redemption 5,467,622
Remeasurement adjustment on ordinary shares subject to possible redemption 13,316,372
Subsequent measurement of ordinary shares subject to possible redemption 2,235,688
Deferred underwriting commissions 3,450,000
Reclassification of value for Class A ordinary shares 86,250,000
Conversion of Class B shares to Class A shares $ 203